droplet-based PCR

The company acquired GnuBio, which was developing a droplet-based sequencing platform, in 2014 for $39.7 million in cash and $10 million in contingent payments. 

The sales decline was largely due to a slowdown in productivity related to the recent launch of the company's global enterprise resource planning system in Western Europe.

A proof-of-principle study has shown a new qPCR device can detect bacterial DNA in under four minutes using droplet size as a readout of amplification.

The company has established a streamlined workflow that customizes and automates key steps of the sample prep process.

The simple, semi-open format uses a microfluidics robot to generate an array of picoliter droplets on a reusable chip. 

The test, which is being developed with a National Science Foundation grant, is based on a novel PCR technology that doesn't require traditional instrumentation.

Researchers from University College London, have shown that a targeted bisulfite sequencing method using RainDance Technologies' microdroplet PCR system can accurately measure DNA methylation levels at sample sizes as low as 100 nanograms.

Researchers from Northwestern University and the University of Chicago have demonstrated in a new study that droplet-based digital PCR offers the ability to detect BCR-ABL1 fusion transcripts with a lower limit of detection and quantification than currently used quantitative PCR

In a study published this month, Bio-Rad researchers have demonstrated the capability of the company's new droplet digital PCR system using DNA-binding dyes with comparable results to TaqMan and that it's possible to use this new dye-based approach for the quantification of multi

University of Arizona scientists have developed a "wire-guided" droplet-based PCR method that they claim can amplify and detect gene targets in real time in about three minutes.

Pages

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.